Speaker illustration

Doctor Jaouad Azzahhafi

St Antonius Hospital, Nieuwegein (Netherlands (The))

Member of:

European Society of Cardiology

Real-world implementation of a genotype-guided p2y12-inhibitor de-escalation strategy in acute coronary syndrome patients

Event: ESC Congress 2024

Topic: Antiplatelet Drugs

Session: Pharmacogenomics, cardio-omics, and cardiovascular drugs

Thumbnail

The clinical implementation of a de-escalation strategy using CYP2C19 genotyping in patients with an acute coronary syndrome: insights from the FORCE-ACS registry

Event: ESC Congress 2023

Topic: Pharmacogenetics

Session: Pharmacogenetics: a tool to guide clinical decisions

Thumbnail

Effects of CYP3A4*22 carrier and CYP3A5 expressor status on clinical outcome in patients treated with ticagrelor for acute coronary syndrome

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Coronary artery disease - Pharmacotherapy 2

Thumbnail

The risk-treatment paradox in acute coronary syndrome patients: Insights from the FORCE-ACS registry

Event: ESC Congress 2021 - The Digital Experience

Topic: Treatment

Session: Acute Coronary Syndromes ePosters

Thumbnail